# CAPRICOR THERAPEUTICS INC (CAPR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CAPR/

- Reporting holders: 4
- Reported value: $27.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GoalVest Advisory LLC](https://holderbook.com/funds/1839307-goalvest-advisory-llc/) | $19.9K | 2,100 | 0.0% | 4 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $3.2K | 338 | 0.0% | 5 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $3.0K | 321 | 0.0% | 5 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $890 | 94 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $27.0K |
| Q2 2026 | 178 | $1.3B |
| Q1 2026 | 181 | $1.2B |
| Q4 2025 | 139 | $1.0B |
| Q3 2025 | 124 | $165.3M |
| Q2 2025 | 122 | $269.9M |
| Q1 2025 | 130 | $204.2M |
| Q4 2024 | 116 | $298.8M |
| Q3 2024 | 82 | $184.5M |
| Q2 2024 | 62 | $33.9M |
| Q1 2024 | 56 | $36.3M |
| Q4 2023 | 38 | $21.7M |